Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Financial documents
General Shareholders’ meetings
Letter to Shareholders – Regulated information
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
Back to agenda
Date
30/05/2025
Place
McCormick Place Chicago, IL & Online
2025 ASCO Annual Meeting
May 30 - June 3rd, 2025